tiprankstipranks
Nascent Biotech Inc. (NBIO)
OTHER OTC:NBIO
US Market
NBIO
Nascent Biotech
RESEARCH TOOLSreports

Nascent Biotech (NBIO) Financial Statements

47 Followers

Nascent Biotech Financial Overview

Nascent Biotech's market cap is currently $51.85K. The company's EPS TTM is $-0.0164; its P/E ratio is -0.02; Nascent Biotech is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Mar 23Mar 22Mar 21Mar 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 1.00M$ 750.00K$ 0.00
Gross Profit$ -320.00K$ 0.00$ 1.00M$ 750.00K$ 0.00
Operating Income$ -2.23M$ -2.16M$ -457.00K$ -1.40M$ -3.45M
EBITDA$ 527.43K$ -1.07M$ 16.78K$ -602.72K$ -470.00K
Net Income$ -2.09M$ -2.80M$ -470.00K$ -959.00K$ -4.00M
Balance Sheet
Cash & Short-Term Investments$ 372.12K$ 172.19K$ 94.41K$ 1.44K$ 3.22K
Total Assets$ 552.12K$ 255.00K$ 105.41K$ 751.43K$ 3.22K
Total Debt$ 122.50K$ 389.59K$ 0.00$ 161.74K$ 138.81K
Net Debt$ -249.62K$ 217.41K$ -94.41K$ 160.30K$ 135.60K
Total Liabilities$ 808.79K$ 1.55M$ 776.89K$ 1.22M$ 2.88M
Stockholders' Equity$ -256.67K$ -1.30M$ -671.48K$ -472.50K$ -2.88M
Cash Flow
Free Cash Flow$ -1.19M$ -1.79M$ 413.48K$ -986.78K$ -554.33K
Operating Cash Flow$ -1.19M$ -1.79M$ 413.48K$ -986.78K$ -554.33K
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 1.39M$ 1.86M$ -320.50K$ 985.00K$ 426.07K
Currency in USD

Nascent Biotech Earnings and Revenue History

Income Statement >

Nascent Biotech Debt to Assets

Balance Sheet >

Nascent Biotech Cash Flow

Cash Flow >

Nascent Biotech Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >